Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination

J Hepatol. 2020 Sep;73(3):490-492. doi: 10.1016/j.jhep.2020.06.008. Epub 2020 Jul 27.

¹ Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
² Department of Metabolism, Digestion & Reproduction, Imperial College London, London, United Kingdom; MRC Centre for Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
³ Journal of Health Communication: International Perspectives, City University of New York (CUNY) Graduate School of Public Health & Health Policy, New York, USA.
⁴ MRC Centre for Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom. Electronic address: m.thursz@imperial.ac.uk.

No abstract available

Keywords: COVID-19; Hepatitis B; Liver cancer; Vaccine hesitancy.

Publication types